Profile Image

Staff Profile

Edit

Career Summary

Qualifications

  • PhD (Medicine), University of Sydney, 16/08/2007
  • Bachelor of Science (Biotechnology)(Honours), University of Newcastle, 27/11/2000

Research

Research keywords

  • breast cancer
  • gene expression
  • miRNA
  • p53

Research expertise

Kelly Avery-Kiejda's research interests are:

  • understanding the molecular mechanisms of cancer development and the resistance of cancer to treatment
  • understanding how p53 function becomes de-regulated in cancer, in particular, melanoma and breast cancer
  • the role of miRNAs in advanced breast cancer

Languages

  • English

Fields of Research

CodeDescriptionPercentage
111200Oncology And Carcinogenesis40
111201Cancer Cell Biology30
111203Cancer Genetics30

Memberships

Body relevant to professional practice.

  • Member - Australian Society for Medical Research (ASMR)
  • Member - The Australian Microarray and Associated Technologies Association
  • Member - Research Enabling Committee of the Hunter Translational Cancer Research Unit
  • Member - Hunter Medical Research Institute Disaster Sub-Plan Committee
  • Member - Australian Society for Biochemistry and Molecular Biology

Committee/Associations (relevant to research).

  • Member - 2013 ASMR Gala Dinner Organising Committee, 6th June, Merewether Surfhouse, Newcastle
  • Member - Organising committee for the 2013 Translational Cancer Research Conference, Newcastle, Australia
  • Member - 2012 ASMR Gala Dinner Organising Committee, 7th June, Customs House, Newcastle
  • Member - Organising committee for the 2012 5th Annual Hunter Cancer Research Symposium, Newcastle, NSW, Australia. Held on 2nd November 2012.
  • Member - Organising committee for the 2012 ASMR Cocktail Party, Newcastle, NSW, Australia. Held on the 21st September,
  • Member - Organising committee for the 4th Annual Hunter Medical Research Institute Cancer Research Program Symposium, Newcastle, NSW, Australia. Held on 4th November, 2011.

Conference Chair

  • Session chair at the 2012 5th Annual Hunter Cancer Research Symposium, Newcastle, NSW, Australia. Held on 2nd November 2012.
  • Session chair at the 2011 4th Annual Hunter Medical Research Institute Cancer Research Program Symposium, Newcastle, NSW, Australia. Held on 4th November, 2011.

NHMRC Committee

  • Member - The NHMRC Postdoctoral Reference Group

National & International Standards Committees.

  • Member - Institutional Biosafety Committee

Appointments

Cameron Melanoma Research Fellow
Calvary Mater Newcastle Hospital (Australia)
01/08/2005 - 01/09/2009
Hunter Translational Cancer Research Unit Fellow
University of Newcastle (Australia)
01/03/2012 - 01/03/2013

Awards

Recognition.

2012Emerging research leaders program
University of Newcastle (Australia)
Program run by Deputy Vice Chancellor (Research) to mentor future research leaders
1999Deans Commendation List
University of Newcastle (Australia)
To recognise well performing undergraduate students
1998Most Outstanding Performance in the subject Cell and Molecular Biology
University of Newcastle (Australia)
To recognise the most outstanding performer in the subject Cell and Molecular Biology

Research Award.

2010HMRI PULSE Education Prize
PULSE (Australia)
2006HMRI Translational Cancer Research Conference Early Career Researcher Poster Award
Hunter Medical Research Institute (Australia)
For the best Early Career researcher poster at the bi-annual Hunter Medical Research Institute (HMRI) Conference on Translational Cancer Research

Scholarship

2001Australian Postgraduate Award
University of Sydney (Australia)
2001Millennium Foundation Stipend Enhancement Grant
The Millennium Foundation, Sydney, NSW, Australia (Australia)
The Millennium Foundation provided a top-up scholarship to recognize outstanding students

Invitations

Small p53 Isoforms- BIG Implications for Prognosis and Treatment Response in Cancer.
22nd Annual Queenstown Molecular Biology Meeting: Cancer Biology Satellite. 26-27th August, 2012, Queenstown, New Zealand (Invited Presenter)
2012
MicroRNA expression profiling in triple-negative breast cancer.
The 9th International RNAi, MicroRNAs and Single Cell Biology Meeting, 1st-2nd May, 2012, Boston , United States (Invited Presenter)
2012
MicroRNA expression profiling in triple-negative breast cancer
Pharmacy Australia Centre of Excellence (PACE), School of Pharmacy, The University of Queensland, Australia (Invited Presenter)
2011
Small isoforms of p53: Do they contribute to melanoma chemoresistance?
Research Seminar Series for the Melanoma Foundation, 15th August 2008., Sydney, NSW, Australia (Invited Presenter)
2008
The role of p53 variants in human melanoma
The Melanoma and Skin Cancer Research Institute (MASCRI) Seminar Series, 20th October 2006, Sydne y, NSW, Australia (Invited Presenter)
2006

Administrative

Administrative expertise

Journal Peer Review

  • Reviewer for: Neoplasia, Clinical Cancer Research, Molecular Cancer Therapeutics, International Journal of Cancer, Clinical & Experimental Metastasis, BMC Cancer, Breast Cancer Research, Cell & Tissue Research, British Journal of Cancer

Grant Peer review

  • Member of the Cancer Australia Grant Review Committee (2013)
  • External assessor for NHMRC project grant funding rounds (2011, 2012, 2014)
  • Assessor for the Hunter Translation Cancer Research Unit pilot project grant rounds (2012)

Teaching

Teaching expertise

Dr Avery-Kiejda is a full-time research academic. Currently, Dr Avery-Kiejda is the mentor of an early career postdoctoral fellow and the supervisor of 4 PhD candidates.

  • She has been the primary and co-supervisor of 2 Honours students (received 1st class Honours).
  • She was the sole supervisor of 3 undergraduate students for their 3rd year projects in the Biotechnology and Biomedical Science degree
  • She was a demonstrator for the subject Molecular Genetics (2000).
Edit

Highlighted Publications

For publications that are currently unpublished or in-press, details are shown in italics.

YearCitationAltmetricsLink
2008Kiejda KA, Zhang XD, Adams LJ, Scott R, Vojtesek B, Lane DP, Hersey P, 'Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin', Clinical Cancer Research, 14 1659-1668 (2008) [C1]
2014Avery-Kiejda KA, Morten B, Wong-Brown MW, Mathe A, Scott RJ, 'The relative mRNA expression of p53 isoforms in breast cancer is associated with clinical features and outcome.', Carcinogenesis, 35 586-596 (2014)
2014Avery-Kiejda KA, Mathe A, Scott RJ, Braye SG, Forbes JF, 'Decreased expression of key tumour suppressor microRNAs is associated with lymph node metastases in triple negative breast cancer', BMC Cancer, 14 (2014)

Publications

For publications that are currently unpublished or in-press, details are shown in italics.

Click on a category title below to expand the list of citations for that specific category.

Journal article (22 outputs)

YearCitationAltmetricsLink
2014Avery-Kiejda KA, Morten B, Wong-Brown MW, Mathe A, Scott RJ, 'The relative mRNA expression of p53 isoforms in breast cancer is associated with clinical features and outcome.', Carcinogenesis, 35 586-596 (2014)
2014Avery-Kiejda KA, Braye SG, Forbes JF, Scott RJ, 'The expression of Dicer and Drosha in matched normal tissues, tumours and lymph node metastases in triple negative breast cancer.', BMC Cancer, 14 253 (2014)
2014Avery-Kiejda KA, Mathe A, Scott RJ, Braye SG, Forbes JF, 'Decreased expression of key tumour suppressor microRNAs is associated with lymph node metastases in triple negative breast cancer', BMC Cancer, 14 (2014)
2014Wong-Brown MW, Avery-Kiejda KA, Bowden NA, Scott RJ, 'Low prevalence of germline PALB2 mutations in Australian triple-negative breast cancer', INTERNATIONAL JOURNAL OF CANCER, 134 301-305 (2014)
2013Bolton KA, Ross JP, Grice DM, Bowden NA, Holliday EG, Avery-Kiejda KA, Scott RJ, 'STaRRRT: a table of short tandem repeats in regulatory regions of the human genome', BMC GENOMICS, 14 (2013) [C1]
2013Bowden NA, Ashton KA, Vilain RE, Avery-Kiejda KA, Davey RJ, Murray HC, et al., 'Regulators of Global Genome Repair Do Not Respond to DNA Damaging Therapy but Correlate with Survival in Melanoma', PLOS ONE, 8 (2013) [C1]
2011Kiejda KA, Wong-Brown M, Scott R, 'Genetic markers in breast cancer - How far have we come from BRCA1?', Asia-Pacific Journal of Molecular Medicine, 1 1-15 (2011) [C1]
2011Wong-Brown M, Nordfors C, Mossman D, Pecenpetelovska G, Kiejda KA, Talseth-Palmer B, et al., 'BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer', Breast Cancer Research and Treatment, 127 853-859 (2011) [C1]
2011Kiejda KA, Bowden NA, Croft AJ, Scurr LL, Kairupan CF, Ashton KA, et al., 'P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation', BMC Cancer, 11 203-219 (2011) [C1]
2010Bowden NA, Ashton KA, Kiejda KA, Zhang XD, Hersey P, Scott R, 'Nucleotide excision repair gene expression after cisplatin treatment in melanoma', Cancer Research, 70 7918-7926 (2010) [C1]
2009Jiang CC, Mao ZG, Kiejda KA, Hersey P, Zhang XD, 'Glucose-regulated protein 78 antagonizes cisplatin and adriamycin in human melanoma cells', Carcinogenesis, 30 197-204 (2009) [C1]
2008Chen LH, Jiang CC, Watts R, Thorne RF, Kiejda KA, Zhang XD, Hersey P, 'Inhibition of endoplasmic reticulum stress-induced apoptosis of melanoma cells by the ARC protein', Cancer Research, 68 834-842 (2008) [C1]
2008Zhu B-K, Wang P, Zhang XD, Jiang CC, Chen LH, Kiejda KA, et al., 'Activation of Jun N-terminal kinase is a mediator of vincristine-induced apoptosis of melanoma cells', Anti-Cancer Drugs, 19 189-200 (2008) [C1]
2008Jiang CC, Lucas K, Kiejda KA, Wade M, Debock CE, Thorne RF, et al., 'Up-regulation of Mcl-1 is critical for survival of human melanoma cells upon endoplasmic reticulum stress', Cancer Research, 68 6708-6717 (2008) [C1]
2008Kiejda KA, Zhang XD, Adams LJ, Scott R, Vojtesek B, Lane DP, Hersey P, 'Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin', Clinical Cancer Research, 14 1659-1668 (2008) [C1]
2007Gillespie S, Kiejda KA, Mhaidat N, Yu FW, Thorne RF, Zhang XD, et al., 'Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response', Cancer Research, 67 5880-5888 (2007) [C1]
2007Chen LH, Jiang CC, Kiejda KA, Wang YF, Thorne RF, Zhang XD, Hersey P, 'Thapsigargin sensitizes human melanoma cells to TRAIL-induced apoptosis by up-regulation of TRAIL-R2 through the unfolded protein response', Carcinogenesis, 28 2328-2336 (2007) [C1]
2007Yu FW, Jiang CC, Kiejda KA, Gillespie S, Zhang XD, Hersey P, 'Apoptosis induction in human melanoma cells by inhibition of MEK is caspase-independent and mediated by the Bcl-2 family members PUMA, Bim, and Mcl-1', Clinical Cancer Research, 13 4934-4942 (2007) [C1]
2007Jiang CC, Li HC, Gillespie S, Yu FW, Kiejda KA, Zhang XD, Hersey P, 'Inhibition of MEK sensitizes human melanoma cells to endoplasmic reticulum stress-induced apoptosis', Cancer Research, 67 9750-9761 (2007) [C1]
2007Mhaidat NM, Wang Y, Kiejda KA, Zhang XD, Hersey P, 'Docetaxel-induced apoptosis in melanoma cells is dependent on activation of caspase-2', Molecular Cancer Therapeutics, 6 752-761 (2007) [C1]
2007Mhaidat NM, Zhang XD, Allen J, Kiejda KA, Scott R, Hersey P, 'Temozolomide induces senescence but not apoptosis in human melanoma cells', British Journal of Cancer, 97 1225-1233 (2007) [C1]
2004Mote PA, Leary JA, Avery KA, Sandelin K, Chenevix-Trench G, Kirk JA, Clarke CL, 'Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A. Genes Chromosomes Cancer 2004;39:236-48. (2004) [C1]
Show 19 more

Conference (45 outputs)

YearCitationAltmetricsLink
2013Wong-Brown MW, Avery-Kiejda KA, Bowden NA, Scott RJ, 'Prevalence of BRCA1 and BRCA2 germline mutations in triple-negative breast cancer.', Translational Cancer Research Conference Abstract booklet, Newcastle, Australia (2013) [E3]
2013Morten B, Scott RJ, Avery-Kiejda KA, 'Microarray analysis of differentially expressed genes in patients with high ¿40p53 expression.', Translational Cancer Research Conference Abstract booklet, Newcastle, Australia (2013) [E3]

Co-authors: Rodney Scott

2013Bolton KA, Avery-Kiejda KA, Grice DM, Holliday EG, Bowden NA, Ross J, Scott RJ, 'STaRRRT: Our new resource for identifying candidates of genetic risk in breast and endometrial cancer.', Translational Cancer Research Conference Abstract booklet, Newcastle, Australia (2013) [E3]
2013Avery-Kiejda KA, Mathe A, Braye SG, Forbes JF, Scott RJ, 'The expression of Dicer and Drosha in lymph node metastases of triple negative breast cancer.', 25th Lorne Cancer Conference Proceedings, Lorne, VIC, Australia (2013) [E3]
2013Zotenko E, Stirzaker C, Song JZ, Qu W, Nair S, Avery-Kiejda KA, et al., 'Genome-wide DNA methylation analysis of archival formalin-fixed paraffin-embedded tissue (FFPET) using MDBCAP-Seq identifies novel epigenetic diagnostic biomarker loci in breast cancer.', 25th Lorne Cancer Conference Proceedings, Lorne, VIC, Australia (2013) [E3]

Co-authors: Rodney Scott

2013Mathe A, Wong-Brown M, Forbes JF, Braye SG, Scott RJ, Avery-Kiejda KA, 'Identification of biomarkers for metastatic spread in triple negative breast cancer.', Translational Cancer Research Conference Abstract booklet, Newcastle, Australia (2013) [E3]
2013Mathe A, Avery-Kiejda KA, Wong-Brown M, Forbes JF, Braye SG, Scott RJ, 'Integration of microRNA and gene expression profiling in triple negative breast cancer to identify possible biomarkers for metastases.', Breakthrough Breast Cancer TNBC Conference Proceedings, London, UK (2013) [E3]
2013Morten B, Mathe A, Scott RJ, Avery-Kiejda KA, 'mRNA expression analysis of p53 isoforms in breast cancer.', 25th Lorne Cancer Conference Proceedings, Lorne, VIC, Australia (2013) [E3]

Co-authors: Rodney Scott

2013Bolton KA, Ross J, Grice DM, Avery-Kiejda KA, Bowden NA, Holliday EG, Scott RJ, 'Role of Short Tandem Repeats in Disease and Evolutionary Mechanisms.', 34th Lorne Genome Conference Proceedings, Lorne, VIC, Australia (2013) [E3]
2013Mathe A, Avery-Kiejda KA, Wong-Brown MW, Forbes JF, Braye SG, Scott RJ, 'Target gene identification of microRNAs associated with lymph node metastases in triple negative breast cancer.', 25th Lorne Cancer Conference Proceedings, Lorne, VIC, Australia (2013) [E3]
2013Wong-Brown M, Li S, Wilkins M, Avery-Kiejda KA, Bowden N, Scott R, 'Targeted resequencing of BRCA1 and BRCA2 in familial breast cancer.', Kathleen Cunningham Foundation Consortium for Research into Familial Aspects of Cancer 2013 Research and Practice Proceedings, Cairns, QLD, Australia. (2013)
2012Wong-Brown M, Li S, Wilkins M, Kiejda KA, Bowden NA, Scott R, 'Targeted resequencing of BRCA1 and BRCA2 in inherited breast cancer', Cancer Research, San Antonio, Texas (2012) [E3]
2012Bolton KA, Ross J, Grice DM, Kiejda KA, Bowden NA, Holliday EG, Scott R, 'Potential role of short tandem repeats in disease processes', Abstracts. 6th Australian Health & Medical Research Congress, Adelaide, SA (2012) [E3]
2012Wong-Brown M, Li S, Wilkins M, Kiejda KA, Bowden NA, Scott R, 'Exploratory targeted resequencing of BRCA1 and BRCA2 in inherited breast cancer', Programme. kConFab Familial Aspects of Cancer: Research & Practice 2012, Kingscliff, NSW (2012) [E3]
2012Kiejda KA, Forbes JF, Braye SG, Scott R, 'Identification of miRNAs associated with lymph node metastasis in triple-negative breast cancer', Human Genome Meeting 2012: Genetics and Genomics in Personalised Medicine. Abstract Book, Sydney, NSW (2012) [E3]
2011Kiejda KA, Forbes JF, Braye SG, Scott R, 'MicroRNA expression profiling in triple-negative breast cancer', Keystone Symposia on Mollecular and Cellular Biology: MicroRNAs and Non-coding RNAs and Cancer, Banff, AL (2011) [E3]
2011Bowden NA, Ashton KA, Kiejda KA, Zhang XD, Hersey P, Scott R, 'Downstream effects of reduction in nucleotide excision repair in response to cisplatin treatment in melanoma', Pigment Cell & Melanoma Research, Tampa, FL (2011) [E3]
2011Kiejda KA, Forbes JF, Hope TL, Braye SG, Scott R, 'Differential expression of miRNAs in triple-negative breast cancer', AMATA Conference Canberra 2011 Handbook, Canberra, ACT (2011) [E3]
2010Kiejda KA, Forbes JF, Braye SG, Scott R, 'The relationship between p53 isofor and estrogen receptor-alpha expression in breast cancer', Sydney Cancer Conference 2010. Profiling Risk, Personalising Treatment and Predicting Outcomes. Conference Program and Abstract Book, Sydney, NSW (2010) [E3]
2010Croft AJ, Kiejda KA, Bowden NA, Zhang X, Scott R, Hersey P, 'Expression profiling on apoptosis-related genes in cisplatin-treated human melanoma cell lines', 22nd Lorne Cancer Conference: Abstracts and Delegate Information, Lorne, Vic. (2010) [E3]
2010Ashton KA, Bowden NA, Vilain RE, Kairupan CF, Kiejda KA, Zhang XD, et al., 'Genetic variation of the base excision repair gene, MUTYH, and melanoma development', Melanoma 2010 Congress. Oral and Poster Abstracts, Sydney, NSW (2010) [E3]
2010Bowden NA, Ashton KA, Kiejda KA, Vilain RE, Braye SG, Kairupan CF, et al., 'Nucleotide excision repair gene expression in melanoma', Melanoma 2010 Congress. Oral and Poster Abstracts, Sydney, NSW (2010) [E3]
2010Ashton KA, Bowden NA, Kairupan CF, Kiejda KA, Zhang XD, Hersey P, Scott R, 'Base excision repair and gene expression profiling in malignant melanoma', Sydney Cancer Conference 2010. Profiling Risk, Personalising Treatment and Predicting Outcomes. Conference Program and Abstract Book, Sydney, NSW (2010) [E3]
2010Wong-Brown M, Bowden NA, Kiejda KA, Scott R, 'BRIP1 and PALB2 mutation detection in Hunter-New England familial breast cancer cohort', 27th HUGO-IABCR Congress 2010. Genomics, Biology and Breast Cancer Treatment. Programme & Abstract Book, Biopolis, Singapore (2010) [E3]
2010Bowden NA, Ashton KA, Kiejda KA, Zhang XD, Hersey P, Scott R, 'Altered nucleotide excision repair gene expression after cisplatin treatment in melanoma', AACR 101st Annual Meeting 2010. Abstracts, Washington, DC (2010) [E3]
2009Zhang XD, Jiang CC, Kiejda KA, Hersey P, 'Up-regulation of Mcl-1 by the unfolded protein response is critical for survival of melanoma cells upon ER stress', 7th World Congress on Melanoma, 5th Congress of the European Association of Dermato-Oncology (EADO): Final Program, Vienna, Austria (2009) [E3]

Co-authors: Xu Zhang

2009Kiejda KA, Scurr LL, Wade MA, Jiang CC, Weir AJW, Bowden NA, et al., 'Cisplatin induces apoptosis independently of Noxa or PUMA in human melanoma cells', 21st Lorne Cancer Conference, Lorne, VIC (2009) [E3]
2008Zhang XD, Jiang CC, Wang YF, Kiejda KA, Hersey P, 'The MEK/ERK pathway potentiates adaptation of human melanoma to endoplasmic reticulum stress', 20th Lorne Cancer Conference, Lorne, VIC (2008) [E3]

Co-authors: Xu Zhang

2008Bowden NA, Ashton KA, Kiejda KA, Zhang XD, Hersey P, Scott R, 'Altered nucleotide excision repair gene expression after cisplatin treatment in melanoma', Proceedings of the Australian Health and Medical Research Congress 2008, Brisbane, QLD (2008) [E3]
2008Kiejda KA, Zhang XD, Adams LJ, Scott R, Vojtesek B, Lane DP, Hersey P, 'The P53 splice variants, P53B and 40P53, are expressed in human melanoma cells and can differnetially regulate the transcription of P53 target genes in response to cisplatin', 20th Lorne Cancer Conference, Lorne, VIC (2008) [E3]

Co-authors: Rodney Scott, Xu Zhang

2008Jiang CC, Wade MA, Kiejda KA, Wang Y, Zhang XD, Hersey P, 'Up-regulation of MCL-1 is critical for survival of human melanoma cells upon ER stress', 20th Lorne Cancer Conference, Lorne, VIC (2008) [E3]

Co-authors: Xu Zhang

2008Zhang XD, Jiang CC, Avery-Kiejda KA, Lucas K, Wade M, Allen J, Hersey P, 'Up-regulation of Mcl-1 by the unfolded protein response is critical for survival of melanoma cells upon ER stress', PIGMENT CELL & MELANOMA RESEARCH (2008) [E3]

Author URL

Co-authors: Xu Zhang

2007Kiejda KA, Zhang XD, Hersey P, 'The P53 splice variant, P53B, is widely expressed in human melanoma', 19th Lorne Cancer Conference, Lorne, VIC (2007) [E3]

Co-authors: Xu Zhang

2007Zhang XD, Jiang CC, Wang YF, Kiejda KA, Gillespie SK, Hersey P, 'Regulation of the BCL-2 family members BIM, PUMA and MCL-1 by MEK/ERK signaling plays a critical role in survival of melanoma cells', 19th Lorne Cancer Conference, Lorne, VIC (2007) [E3]

Co-authors: Xu Zhang

2007Zhang XD, Jiang CC, Wang YF, Kiejda KA, Hersey P, 'The MEK-ERK pathway potentiates adaptation of melanoma to endoplasmic reticulum stress', 4th Garvan Signalling Symposium. Conference Proceedings, Sydney, NSW (2007) [E3]

Co-authors: Xu Zhang

2007Jiang CC, Chen IH, Kiejda KA, Gillespie SK, Hersey P, Zhang XD, 'The unfolded protein response induced by tunicamycin or thapsigargin sensitizes human melanoma cells to trail-induced apoptosis by selective up-regulaton of trail-R2 on te cell surface', 19th Lorne Cancer Conference, Lorne, VIC (2007) [E3]

Co-authors: Xu Zhang

2007Kiejda KA, Zhang XD, Adams LJ, Scott R, Vojtesek B, Lane DP, Hersey P, 'MEK/ERK-mediated regulation of the Bcl-2 family members Mcl-1, PUMA, and Bim contributes to survival of human melanoma cells', 4th Garvan Signalling Symposium. Conference Proceedings, Sydney, NSW (2007) [E3]

Co-authors: Rodney Scott, Xu Zhang

2007Kiejda KA, Zhang XD, Adams LJ, Scott R, Vojtesek B, Lane DP, Hersey P, 'Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by cisplatin', 4th Garvan Signalling Symposium. Conference Proceedings, Sydney, NSW (2007) [E3]

Co-authors: Rodney Scott, Xu Zhang

2007Jiang CC, Wang YF, Kiejda KA, Gillespie SK, Zhang XD, Hersey P, 'Regulation of the Bcl-2 family members Bim, PUMA and Mcl-1 by MEK/ERK signaling plays a critical role in survival of melanoma cells', AACR Meeting Abstracts Online (Abstracts of the 98th AACR Annual Meeting), Los Angeles (2007) [E3]

Co-authors: Xu Zhang

2006Kiejda KA, Zhang XD, Hersey P, 'Expression of P53 variants in human melanoma', HMRI Conference on Translational Cancer Research. Molecular Mechanisms and Implications for Treatment, Newcastle, NSW (2006) [E3]

Co-authors: Xu Zhang

2006Jiang CC, Wang YF, Kiejda KA, Zhang XD, Hersey P, 'CD133, A potential marker for cancer stem cells in melanoma', HMRI Conference on Translational Cancer Research. Molecular Mechanisms and Implications for Treatment, Newcastle, NSW (2006) [E3]

Co-authors: Xu Zhang

2006Kiejda KA, Zhang XD, Hersey P, 'p53 variants in human melanoma', 13th Annual p53 Workshop. Program & Abstracts, New York (2006) [E3]

Co-authors: Xu Zhang

2006Wang YF, Jiang CC, Kiejda KA, Zhang XD, Hersey P, 'Suppression of the BH3-only proteins BUM and PUMA by MEK/ERK signaling plays a crucial role in maintaining survival of melanoma cells', HMRI Conference on Translational Cancer Research. Molecular Mechanisms and Implications for Treatment, Newcastle, NSW (2006) [E3]

Co-authors: Xu Zhang

2004Avery KA, Graham JD, Defazio A, Clarke CL, 'Endogenous levels of BRCA1 regulate progestin signalling' (2004) [E3]
2004Avery KA, Graham JD, Defazio A, Clarke CL, 'Co-localisation of the progesterone receptor with BRCA1 in human breast cancer cells' (2004) [E3]
Show 42 more
Edit

Grants and Funding

Summary

Number of grants21
Total funding$1,463,025

- Indicates that the researcher may be seeking students for this project.

Click on a grant title below to expand the full details for that specific grant.

2013 (2 grants)

The function of the delta-40p53 isoform in breast cancer.$30,000
Funding Body: Hunter Medical Research Institute

Project Team
Doctor Kelly Kiejda, Miss Brianna Morten, Professor Rodney Scott
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$30,00020132013
GNo:G1300583

miRNA regulation of growth, invasion and treatment response in triple negative breast cancer$10,000
Funding Body: Hunter Medical Research Institute

Project Team
Doctor Kelly Kiejda, Miss Andrea Mathe
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$10,00020132013
GNo:G1300728

2012 (5 grants)

The Hunter Cancer Biobank (HCB): Maximising community value through validation, annotation and distribution throughout NSW$292,300
Funding Body: Cancer Institute NSW

Project Team
Professor John Forbes, Conjoint Professor Stephen Ackland, Professor Rodney Scott, Conjoint Associate Professor Barbara Young, Professor Hubert Hondermarck, Conjoint Professor Leonie Ashman, Professor Xu Dong Zhang, Doctor Kelly Kiejda, Doctor Nikki Verrills, Doctor Jennette Sakoff, Ms Janine Lombard, Doctor Jude Weidenhofer, Doctor Pradeep Tanwar
SchemeRole
Infrastructure GrantsInvestigator
Total AmountFunding StartFunding Finish
$292,30020122014
GNo:G1200798

p53 isoforms in breast cancer - MM Sawyer Estate Scholarship$75,000
Funding Body: Hunter Medical Research Institute

Project Team
Doctor Kelly Kiejda, Professor Rodney Scott
SchemeRole
Mary Minto Sawyer GrantChief Investigator
Total AmountFunding StartFunding Finish
$75,00020122014
GNo:G1200615

Small p53 isoforms, BIG implications for treatment response in breast cancer$60,000
Funding Body: Hunter Medical Research Institute

Project Team
Doctor Kelly Kiejda, Professor Rodney Scott
SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$60,00020122014
GNo:G1200322

2011 Emerging Research Leaders Program$15,000
Funding Body: University of Newcastle

Project Team
Doctor Kelly Kiejda
SchemeRole
Emerging Research Leaders ProgramChief Investigator
Total AmountFunding StartFunding Finish
$15,00020122012
GNo:G1200817

Ninth International NRAi, MicroRNAs & Single Cell Biology - 2012, Hilton Garden Inn, Waltham, Massachusetts, USA, 1 - 2 May 2012$2,000
Funding Body: University of Newcastle - Faculty of Health

Project Team
Doctor Kelly Kiejda
SchemeRole
Travel GrantChief Investigator
Total AmountFunding StartFunding Finish
$2,00020122012
GNo:G1200588

2011 (3 grants)

p53 isoforms, a prognostic indicator in breast cancer?$45,000
Funding Body: Hunter Medical Research Institute

Project Team
Doctor Kelly Kiejda, Professor Rodney Scott, Professor John Forbes
SchemeRole
Breast Cancer Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$45,00020112011
GNo:G1001006

PULSE Education Prize$4,000
Funding Body: Hunter Medical Research Institute

Project Team
Doctor Kelly Kiejda
SchemeRole
PULSE Education PrizeChief Investigator
Total AmountFunding StartFunding Finish
$4,00020112011
GNo:G1001021

Annual meeting fo the Australasian Microarray & Associated Technologies Association (AMATA), Shine Dome in Canberra, 9 - 12 October 2011$1,375
Funding Body: University of Newcastle - Faculty of Health

Project Team
Doctor Kelly Kiejda
SchemeRole
Travel GrantChief Investigator
Total AmountFunding StartFunding Finish
$1,37520112011
GNo:G1100938

2010 (1 grants)

The identification of microRNA's as therapeutic targets for the treatment of advanced breast cancer$21,600
Funding Body: Hunter Medical Research Institute

Project Team
Doctor Kelly Kiejda, Professor Rodney Scott, Professor John Forbes
SchemeRole
Research GrantChief Investigator
Total AmountFunding StartFunding Finish
$21,60020102010
GNo:G0900144

2009 (4 grants)

Targeting p53 isoforms, delta-40p53 and p53-beta, to promote chemo-sensitivity in human melanoma$272,000
Funding Body: Cancer Council NSW

Project Team
Professor Xu Dong Zhang, Conjoint Professor Peter Hersey, Doctor Kelly Kiejda
SchemeRole
Research GrantInvestigator
Total AmountFunding StartFunding Finish
$272,00020092011
GNo:G0188913

Targeting p53 isoforms, delta-40p53 and p53-beta, to promote chemo-sensitivity in human melanoma$75,000
Funding Body: Cancer Australia

Project Team
Doctor Kelly Kiejda, Professor Xu Dong Zhang, Conjoint Professor Peter Hersey
SchemeRole
Priority-driven Collaborative Cancer Research SchemeChief Investigator
Total AmountFunding StartFunding Finish
$75,00020092009
GNo:G0188914

Targeting p53 isoforms in human melanoma$30,000
Funding Body: Calvary Mater Newcastle

SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$30,00020092009
GNo:174562457

The microRNA signature of endoplasmic reticulum stress in melanoma$10,000
Funding Body: Calvary Mater Newcastle

SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$10,00020092009
GNo:174562465

2007 (3 grants)

Characterization of p53 isoforms in human melanoma: do they play a role in chemoresistance?$75,000
Funding Body: Cure Cancer Australia Foundation

SchemeRole
Research GrantInvestigator
Total AmountFunding StartFunding Finish
$75,00020072007
GNo:174562473

The role of p53 Isoforms in chemoresistances of human melanoma$20,000
Funding Body: Hunter Medical Research Institute

Project Team
Professor Xu Dong Zhang, Doctor Kelly Kiejda
SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$20,00020072007
GNo:G0187239

The role of p53 isoforms in chemoresistance of human melanoma$10,000
Funding Body: Calvary Mater Newcastle

SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$10,00020072007
GNo:174562481

2006 (1 grants)

Cameron Fellowship in Melanoma Research$332,000
Funding Body: Melanoma and Skin Cancer Research Institute

SchemeRole
fellowshipChief Investigator
Total AmountFunding StartFunding Finish
$332,00020062009
GNo:174562489

2001 (2 grants)

Australian Postgraduate Award$64,750
Funding Body: Department of Education, Training & Youth Affairs

SchemeRole
Scholarship support for PhDChief Investigator
Total AmountFunding StartFunding Finish
$64,75020012004
GNo:174562497

Millennium Foundation Stipend Enhancement Grant$18,000
Funding Body: Millennium Foundation

SchemeRole
Stipend enhancement grantChief Investigator
Total AmountFunding StartFunding Finish
$18,00020012004
GNo:174562505
Edit

Research Supervision

Number of current supervisions3
Total current UoN PhD EFTSL0.95

For supervisions undertaken at an institution other that the University of Newcastle, the institution name is listed below the program name.

Current Supervision

CommencedProposed
Completion
ProgramSupervisor TypeResearch Title
20122016PhD (Medical Genetics)Co-SupervisorThe Functional Role of MicroRNAs Associated With Lymph Node Metastasis in Triple Negative Breast Cancer
20122016PhD (Medical Genetics)Principal Supervisorp53 Isoforms in Breast Cancer
20102016PhD (Medical Genetics)Co-SupervisorRole of Tandem Repeats in Genetic Susceptibility to Breast Cancer

Past Supervision

YearProgramSupervisor TypeResearch Title
2014PhD (Medical Genetics)Co-SupervisorThe Contribution of Genetic Susceptibility to Breast Cancer
2011Honours Medical Science
University of Newcastle
Principal Supervisorp53 isoforms in breast cancer
Edit

Dr Kelly Kiejda

Work Phone4042 0309
Fax4042 0031
Email
PositionResearch Fellow
Information Based Medicine
School of Biomedical Sciences and Pharmacy
Faculty of Health and Medicine
The University of Newcastle, Australia
Focus AreaMedical Genetics
Office
Rm 3104, Lvl 3, West,
Hunter Medical Research Institute ,
Lot 1 Kookaburra Circuit, New Lambton Heights, NSW 2305
URL:www.newcastle.edu.au/profile/kelly-kiejda